TV Video: Hannah - Health Insurance Story. View her fight for insurance coverage for the SCOT Trial, with David Becker, ISN Assistant News Guide.
Tackle Scleroderma! Join/Shop/Donate
SCLERO.ORG by the nonprofit International Scleroderma Network (ISN) is a full-service nonprofit charitable foundation providing stellar research, support, education and awareness
Search sclero.org:

Scleroderma Newsroom
janeywillisHello, I am Janey Willis, ISN News Director and ISN Asst. Webmaster. David Becker, ISN Assistant News Guide researches our Autoimmune News section. Jeannie McClelland, ISN Assistant News Guide, researches Scleroderma Medical and Media News. Assistant News Guide Lisa Bulman posts these stories to our Sclero Forums.
Scleroderma Medical News
Autoimmune News
Media Stories
ISN Website News
Donations & In Memory
New Personal Stories
Autoimmune Medical News by Date
February 2007
Sjögren's syndrome (SS) is associated with and not secondary to systemic sclerosis (SSc). SS associated with SSc has the same features as pSS, but SSc seems to be less serious. Moreover, the association of SS and SSc is frequently accompanied by a spreading of autoimmunity. Rheumatology. Vol 46, Number 2. Pp. 321-326. Feb 07. (Also see: Sjogren's Syndrome )
Researchers study the possible relationship between myopathies and celiac disease. The scientists are considering the possibility that, at least in part, some inflammatory myopathies are a clinical expression of intolerance to gluten, though they point out the need for more studies to be carried out to confirm or support these findings. innovations report. 02/23/07. (Also see: Celiac Disease, Bowel Dysfunction, and Dermatomyositis and Polymyositis
Scientists Learn The Origin Of Rogue B Cells. Researchers have provided some new clues into one likely factor for the immune system turning against parts of the body it is designed to protect, leading to autoimmune disease: the early development of immune system cells called B cells. Medical News Today. 02/11/07. (Also see: Causes of Scleroderma: B Cells and T Cells
Insulin-like Growth Receptors (IGF-1R) implicated in the pathogenesis of Grave's Disease. Investigators have found evidence that continues to implicate insulin-like growth factor receptor (IGF-1R) in the development of Graves� disease. The discovery of these mechanisms in a similar class of autoimmune diseases supports the belief that a single biological mechanism is activating a variety of autoimmune diseases. RxPG News. 02/16/07. (Also see: Grave's Disease )
Discovery May Lead to Novel Treatments for Autoimmune and Chronic Inflammatory Diseases. For years, doctors have used IVIG to treat patients with autoimmune and chronic inflammatory diseases, but just how the therapy works has remained a mystery. Some researchers have shown that IVIG works, in part, by activating a receptor known as FcγRIIb, which then suppresses auto-antibody-mediated inflammation. Newswise. 01/26/07. (Also see: Clinical Trials: Positive Results: IVIG, Medications, Dermatomyositis, and Myasthenia Gravis )
Joslin-led study uncovers role of appetite hormone MCH in insulin production. Findings may lead to treatments that stimulate insulin production. A new Joslin Diabetes Center-led study has shown conclusively that a neuropeptide, melanin concentrating hormone (MCH), found in the brain and known for its role in increasing appetite in people, plays a role in the growth of insulin-producing beta cells and the secretion of insulin. EurekAlert! 01/25/07. (Also see: Diabetes )
 
Go to Autoimmune News: January 2007
 
SCLERO.ORG is brought to you by the nonprofit International Scleroderma Network (ISN). The ISN is a full-service nonprofit scleroderma charitable foundation providing stellar research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension.
  1. Post a message in Sclero Forums!
  2. Email: isn@sclero.org
  3. English Email Form
  4. Español Email Form
  5. Italiano Email Form
International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702
United States
Toll Free Hotline in U.S.
Hours: 9am-3pm CST only.
Please leave a complete message, in English.
1-800-564-7099
Direct Line
1-952-583-5735
We are also known as the Scleroderma from A to Z web site.
© Copyright 1998-2009 International Scleroderma Network
All Rights Reserved